US Patent Issued to JENKEM TECHNOLOGY Co. LTD. (TIANJIN) on Sept. 29 for "Antitumor pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,289, issued on Sept. 29, was assigned to JENKEM TECHNOLOGY Co. LTD. (TIANJIN) (Tianjin, China).

"Antitumor pharmaceutical composition and use thereof" was invented by Qingbin Wang (Tianjin, China), Juan Shi (Tianjin, China), Jingyun Hu (Tianjin, China) and Xuan Zhao (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antitumor pharmaceutical composition and an application thereof. Active ingredients of the antitumor pharmaceutical composition contain a polyethylene glycol-modified camptothecin derivative (in particular, polyethylene glycol-modified irinotecan) and temozolomide. It is proved by means of animal experiments that the admi...